Barclays downgrades Stryker outlook to “underweight” — 5 key notes

By Laura Dyrda

Barclays downgraded Stryker shares, according to a Woodbridge Daily report.

Here are five things to know about the downgrade:

Advertisement

1. Stryker’s shares currently have an “underweight” rating, down from “equal weight.”

2. Price target for the shares went from $88 to $92 per share.

3. Stryker stock price is expected to reach $99.79 in the short term.

4. There are 14 analysts agreeing with the consensus, with a higher short term estimate at $105 and lower at $88.

5. The market cap is $34.7 billion with 378.9 million shares outstanding.

Stryker shares did drop 1.56 percent over the past week but the big picture remains bullish, according to the report, and shares posted positive gains of 1.17 percent over the last four weeks.

READ MORE HERE

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement